Literature DB >> 19842197

Conversion disorder in women with the FMR1 premutation.

Andreea L Seritan1, Andrea Schneider, John M Olichney, Maureen A Leehey, R Scott Akins, Randi J Hagerman.   

Abstract

Women with fragile X mental retardation (FMR1) gene premutations (55-200 CGG repeats) were until recently believed to be unaffected. It is now known that up to 8% of older female FMR1 premutation carriers develop fragile X-associated tremor/ataxia syndrome (FXTAS). Female carriers may also develop primary ovarian insufficiency, thyroid disease, hypertension, seizures, peripheral neuropathy, and fibromyalgia. We present a 60-year-old woman with FMR1 premutation who had depression, anxiety, and conversion disorder with seizures. The FMR1 premutation with its associated mRNA toxicity is postulated as an underlying neurobiological mechanism of conversion symptoms, through functional and structural neural dysconnectivity. Copyright 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19842197      PMCID: PMC2783547          DOI: 10.1002/ajmg.a.33054

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  40 in total

Review 1.  Conversion hysteria: lessons from functional imaging.

Authors:  Deborah N Black; Andreea L Seritan; Katherine H Taber; Robin A Hurley
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2004       Impact factor: 2.198

2.  The fragile X prevalence paradox.

Authors:  Paul J Hagerman
Journal:  J Med Genet       Date:  2008-04-15       Impact factor: 6.318

3.  Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation.

Authors:  David Hessl; Flora Tassone; Danuta Z Loesch; Elizabeth Berry-Kravis; Maureen A Leehey; Louise W Gane; Ingrid Barbato; Cathlin Rice; Emma Gould; Deborah A Hall; James Grigsby; Jacob A Wegelin; Susan Harris; Foster Lewin; Dahlia Weinberg; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-11-05       Impact factor: 3.568

4.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

5.  Evidence of depressive symptoms in fragile-X syndrome premutated females.

Authors:  Laia Rodriguez-Revenga; Irene Madrigal; Montserrat Alegret; Mónica Santos; Montserrat Milà
Journal:  Psychiatr Genet       Date:  2008-08       Impact factor: 2.458

Review 6.  Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts.

Authors:  Karin Roelofs; Philip Spinhoven
Journal:  Clin Psychol Rev       Date:  2007-07-17

7.  Reduced Hippocampal Activation During Recall is Associated with Elevated FMR1 mRNA and Psychiatric Symptoms in Men with the Fragile X Premutation.

Authors:  Kami Koldewyn; David Hessl; John Adams; Flora Tassone; Paul J Hagerman; Randi J Hagerman; Susan M Rivera
Journal:  Brain Imaging Behav       Date:  2008-01-18       Impact factor: 3.978

Review 8.  Clinical applications of cognitive event-related potentials in Alzheimer's disease.

Authors:  John M Olichney; Dieter G Hillert
Journal:  Phys Med Rehabil Clin N Am       Date:  2004-02       Impact factor: 1.784

9.  Reduced sensitivity of the N400 and late positive component to semantic congruity and word repetition in left temporal lobe epilepsy.

Authors:  John M Olichney; Brock R Riggins; Dieter G Hillert; Ralph Nowacki; Evelyn Tecoma; Marta Kutas; Vicente J Iragui
Journal:  Clin Electroencephalogr       Date:  2002-07

Review 10.  Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

Authors:  Randi J Hagerman; Deborah A Hall; Sarah Coffey; Maureen Leehey; James Bourgeois; John Gould; Lin Zhang; Andreea Seritan; Elizabeth Berry-Kravis; John Olichney; Joshua W Miller; Amy L Fong; Randall Carpenter; Cathy Bodine; Louise W Gane; Edgar Rainin; Hillary Hagerman; Paul J Hagerman
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more
  8 in total

1.  Associations of specific psychiatric disorders with isolated focal dystonia, and monogenic and idiopathic Parkinson's disease.

Authors:  Susanne Steinlechner; Johann Hagenah; Hans-Jürgen Rumpf; Christian Meyer; Ulrich John; Tobias Bäumer; Norbert Brüggemann; Meike Kasten; Alexander Münchau; Christine Klein; Rebekka Lencer
Journal:  J Neurol       Date:  2017-04-11       Impact factor: 4.849

2.  Ages of Onset of Mood and Anxiety Disorders in Fragile X Premutation Carriers.

Authors:  Andreea L Seritan; James A Bourgeois; Andrea Schneider; Yi Mu; Randi J Hagerman; Danh V Nguyen
Journal:  Curr Psychiatry Rev       Date:  2013-02

3.  Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  Andreea L Seritan; Kyoungmi Kim; Ian Benjamin; Ioana Seritan; Randi J Hagerman
Journal:  J Geriatr Psychiatry Neurol       Date:  2016-09-21       Impact factor: 2.680

4.  PSYCHIATRIC DISORDERS ASSOCIATED WITH FXTAS.

Authors:  Andreea L Seritan; Melina Ortigas; Stefan Seritan; James A Bourgeois; Randi J Hagerman
Journal:  Curr Psychiatry Rev       Date:  2013

5.  COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS.

Authors:  Andreea Seritan; Jennifer Cogswell; Jim Grigsby
Journal:  Curr Psychiatry Rev       Date:  2013-02

Review 6.  Current research, diagnosis, and treatment of fragile X-associated tremor/ataxia syndrome.

Authors:  Zukhrofi Muzar; Reymundo Lozano
Journal:  Intractable Rare Dis Res       Date:  2014-11

7.  Screening for the presence of FMR1 premutation alleles in a Spanish population with fibromyalgia.

Authors:  Loreto Martorell; Mireia Tondo; Ferrán Garcia-Fructuoso; Montserrat Naudo; Cayetano Alegre; Josep Gamez; Jordi Genovés; Pilar Poo
Journal:  Clin Rheumatol       Date:  2012-08-18       Impact factor: 2.980

Review 8.  Neurocognitive endophenotypes in CGG KI and Fmr1 KO mouse models of Fragile X-Associated disorders: an analysis of the state of the field.

Authors:  Michael R Hunsaker
Journal:  F1000Res       Date:  2013-12-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.